Skip to content

Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake

Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake in Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02568592
Enrollment
16
Registered
2015-10-06
Start date
2015-03-31
Completion date
2016-06-30
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Modification

Brief summary

The capacity to burn fat as fuel for exercise may have important implications for sporting performance, with dietary fat intake positively influencing this ability. Endurance performance and the ability to burn fat will be measured in women runners following the consumption of 3 diets varying in the amount of fat and carbohydrate.

Detailed description

Dietary fat intake positively influences the ability to burn fat during exercise in women but not men, whereas carbohydrate intake negatively influences fat oxidation in both sexes. The independent nature of dietary fat intake as a predictor of the ability to burn fat in women suggests that in conditions of adequate carbohydrate intake providing additional fat may increase fat oxidation in women whereas it does not in men. It is of interest to explore if indeed women are responsive (i.e., increase in fat oxidation) to short-term increases in dietary fat intake induced by overfeeding (adequate carbohydrate) or if as appears to be the case in men reduced carbohydrate intake as typically employed in high-fat, low carbohydrate dietary studies is also a prerequisite for enhancing fat oxidation in women, and whether this translates into a difference in exercise endurance performance.

Interventions

DIETARY_SUPPLEMENTHigh Fat

High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)

DIETARY_SUPPLEMENTNormal

Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)

DIETARY_SUPPLEMENTNormal + Extra Fat

Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%). Carbohydrate and protein intake identical in absolute amounts to NORMAL, with an additional 30% extra energy coming from fat.

Sponsors

GlaxoSmithKline
CollaboratorINDUSTRY
University of Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \>17.0 \< 25 kg/m2 * Good General Health * Accustomed to vigorous physical activity * Run \> 2 times per week * V̇O2max \>50ml/kg/min * Weight Stable \> last 6months * Non Smoker * Pre-menopausal, and either eumenorrheic and regularly menstruating, or using monophasic hormonal oral contraceptives for \> 3 months.

Exclusion criteria

* Currently taking part in another scientific/clinical study * Taking any prescription drug / supplement thought to influence metabolism * Following unusual dietary practices (such as intermittent fasting or low carbohydrate diets) * Pregnant * Breast Feeding

Design outcomes

Primary

MeasureTime frameDescription
Rates of fat oxidation during exercise90 minutes of sub-maximal exerciseRates of fat oxidation to be measured via indirect calorimetry during 90 minutes of submaximal exercise

Secondary

MeasureTime frameDescription
5km running performanceImmediately following measurement of Primary Outcome measureTime to complete 5km on a treadmill
Change in plasma glucose concentration90 minutes sub-maximal exerciseArea under the plasma concentration versus time curve (AUC) of glucose
Change in Free Fatty Acid concentration90 minutes sub-maximal exerciseArea under the plasma concentration versus time curve (AUC) of Free Fatty Acid
Change in plasma glycerol concentration90 minutes sub-maximal exerciseArea under the plasma concentration versus time curve (AUC) of glycerol

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026